Cystatin C and risk of hip fractures in older women

Journal of Bone and Mineral Research

Volumn 28, Issue 6, 2013, Pages 1275-1282

  Ensrud, Kristine E ^a,b,c   Parimi, Neeta ^d   Cauley, Jane A ^e   Ishani, Areef ^a,c   Slinin, Yelena ^a,c   Hillier, Teresa A ^f   Taylor, Brent C ^b,c   Steffes, Michael ^a   Cummings, Steven R ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

CYSTATIN C; ELDERLY; HIP FRACTURE; RENAL FUNCTION; WOMEN

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIFEDIOL; CREATININE; CYSTATIN C; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BODY MASS; BONE DENSITY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FEMUR NECK FRACTURE; FEMUR TROCHANTERIC FRACTURE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH STATUS; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PROTEIN BLOOD LEVEL; SENESCENCE; SMOKING;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HIP FRACTURES; HUMANS; MALE; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; TIME FACTORS;

EID: 84878260525     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1858     Document Type: Article

References (35)

1. United States Renal Data System. Annual Data Report (ADR), Volume One: Atlas of Chronic Kidney Disease in the United States [Internet]. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009 [cited 2013 Jan 13]. Available from http://www.usrds.org/ atlas09.aspx. 2009.
2. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007 Mar; 22 (3): 465-75.
3. Seronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP., Cystatin C: current position and future prospects. Clin Chem Lab Med. 2008; 46 (12): 1664-86.
4. Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J., Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2007 Jan; 18 (1): 282-6.
5. LaCroix AZ, Lee JS, Wu L, Cauley JA, Shlipak MG, Ott SM, Robbins J, Curb JD, Leboff M, Bauer DC, Jackson RD, Kooperberg CL, Cummings SR., Women's Health Initiative Observational. Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc. 2008 Aug; 56 (8): 1434-41.
6. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P, Vogt TM., Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990 Feb 2; 263 (5): 665-8.
7. Prentice R., A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986; 73: 1-11.
8. Erlandsen EJ, Randers E, Kristensen JH., Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999 Feb; 59 (1): 1-8.
9. Inker LA, Eckfeldt J, Levey AS, Leiendecker-Foster C, Rynders G, Manzi J, Waheed S, Coresh J., Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011 Oct; 58 (4): 682-4.
10. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van LF, Bruce RD III, Zhang YL, Greene T, Levey AS., Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008 Mar; 51 (3): 395-406.
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van LF, Greene T, Coresh J., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May 5; 150 (9): 604-12.
12. Gregg EW, Cauley JA, Stone K, Thompson TJ, Bauer DC, Cummings SR, Ensrud KE., Relationship of changes in physical activity and mortality among older women. JAMA. 2003 May 14; 289 (18): 2379-86.
13. Paffenbarger RS Jr, Wing AL, Hyde RT., Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978 Sep; 108 (3): 161-75.
14. Sheikh JI, Yesavage JA., Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986; 5 (1/2): 165-73.
15. Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll ES, Nevitt MC, Fox KM, Cummings SR., Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res. 1995 Nov; 10 (11): 1778-87.
16. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA., Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar; 56 (3): M146-56.
17. Ensrud KE, Ewing SK, Fredman L, Hochberg MC, Cauley JA, Hillier TA, Cummings SR, Yaffe K, Cawthon PM., Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab. 2010 Dec; 95 (12): 5266-73.
18. Singh RJ, Taylor RL, Reddy GS, Grebe SK., C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006 Aug; 91 (8): 3055-61.
19. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS., Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006 Aug 15; 145 (4): 237-46.
20. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR., Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007 Jan 22; 167 (2): 133-9.
21. Francis RM, Peacock M, Barkworth SA., Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing. 1984 Jan; 13 (1): 14-20.
22. Vieth R, Ladak Y, Walfish PG., Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab. 2003 Jan; 88 (1): 185-91.
23. Agency for Healthcare Research and Quality. Effectiveness and safety of vitamin D in relation to bone health [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; Aug [cited 2013 Jan 13] Available from http://archive.ahrq.gov/clinic/tp/vitadtp.htm. 2007.
24. Agency for Healthcare Research and Quality. Vitamin D and calcium: a systematic review of health outcomes. Rockville, MD: Agency for Healthcare Research and Quality; May [cited 2013 Jan 13] Available from http://www.ahrq.gov/clinic/tp/vitadcaltp.htm. 2010.
25. Sakuma M, Endo N, Oinuma T, Hayami T, Endo E, Yazawa T, Watanabe K, Watanabe S., Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int. 2006; 17 (11): 1608-4.
26. von Muhlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E., Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int. 2005 Dec; 16 (12): 1721-6.
27. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J., Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2002 Jun 24; 162 (12): 1401-8.
28. Francis ME, Eggers PW, Hostetter TH, Briggs JP., Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int. 2004 Jul; 66 (1): 303-12.
29. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM., Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003 Jan 7; 107 (1): 87-92.
30. Ensrud KE, Barbour K, Canales MT, Danielson ME, Boudreau RM, Bauer DC, LaCroix AZ, Ishani A, Jackson RD, Robbins JA, Cauley JA., Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI). Osteoporos Int. 2012 Mar; 23 (3): 887-99.
31. Odden MC, Chertow GM, Fried LF, Newman AB, Connelly S, Angleman S, Harris TB, Simonsick EM, Shlipak MG., Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol. 2006 Dec 15; 164 (12): 1180-9.
32. Ishani A, Paudel M, Taylor BC, Barrett-Connor E, Jamal S, Canales M, Steffes M, Fink HA, Orwoll E, Cummings SR, Ensrud KE., Osteoporotic Fractures in Men (MrOS) Study Group. Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int. 2008 Nov; 19 (11): 1549-56.
33. Elliott MJ, Tonelli M, Manns B, Kline GA, James MT, Quinn RR, Palacios-Derflingher L, Ronksley PE, Hemmelgarn BR., Fracture risk is not increased in patients with chronic kidney disease. Paper presented at: Canadian Society of Nephrology 2012 Scientific Meeting; 2012 April 25-29; St. John's, Newfoundland, Canada.
34. Stevens LA, Levey AS., Chronic kidney disease in the elderly-how to assess risk. N Engl J Med. 2005 May 19; 352 (20): 2122-4.
35. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS., Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009 Mar; 75 (6): 652-60.